Palvella Therapeutics, Inc. (PVLA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.18B |
| Enterprise Value | 1.12B |
| P/E Ratio | -30.18 |
| PEG Ratio | -1.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 9.65 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -38.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.24 |
| Return On Equity | -0.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -35.9M |
| Net Income | -41.72M |
| Diluted EPS | -3.71 |
| Total Cash | 250.58M |
| Total Cash/Share | 17.45 |
| Total Debt | 535,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 21.18 |
| Book Value Per Share | 15.11 |
| 52-Week Change | 190.74 |
| 52-Week High | 161.38 |
| 52-Week Low | 49.81 |
| Moving Average 50 Days | 142.24 |
| Moving Average 200 Days | 115.61 |
| Average Volume | 251,647 |
| Shares Outstanding | 14.34M |
| % Held by Institutions | 120.89 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
| Last Split Date | April 23, 2024 |